Back
Marine Products 10K Form
Sell
38
MPX
Marine Products
Last Price:
9.88
Seasonality Move:
4.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | MPX/Marine Products Quarterly |
2023-10-26 | 10Q | MPX/Marine Products Quarterly |
2023-07-28 | 10Q | MPX/Marine Products Quarterly |
2023-04-28 | 10Q | MPX/Marine Products Quarterly |
2022-10-28 | 10Q | MPX/Marine Products Quarterly |
2022-07-29 | 10Q | MPX/Marine Products Quarterly |
Receive MPX News And Ratings
See the #1 stock for the next 7 days that we like better than MPX
MPX Financial Statistics
Sales & Book Value
Annual Sales: | $383.73M |
---|---|
Cash Flow: | $3.23M |
Price / Cash Flow: | 9.27 |
Annual Sales: | $3.71 |
Price / Book: | 2.68 |
Profitability
EPS (TTM): | 0.53000 |
---|---|
Net Income (TTM): | $19.01M |
Gross Margin: | $90.38M |
Return on Equity: | 13.37% |
Return on Assets: | 10.04% |
Marine Products Earnings Forecast
Key Marine Products Financial Ratios
- The Gross Profit Margin over the past 26 years for MPX is 23.55%.
- The Selling, General & Administrative Expenses for MPX have been equal to 11.26% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of MPX is 10.87% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 17 years.
Marine Products Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Leisure Products |
Sector: | Consumer Discretionary |
Current Symbol: | MPX |
CUSIP: | 568427 |
Website: | marineproductscorp.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.69 |
Quick Ratio: | 2.4 |
Price-to-Earnings
Trailing P/E Ratio: | 8.21 |
---|---|
Forward P/E Ratio: | 19.88 |
MPX Technical Analysis vs Fundamental Analysis
Sell
38
Marine Products (MPX)
is a Sell
Is Marine Products a Buy or a Sell?
-
Marine Products stock is rated a Sell
The current Marine Products [MPX] share price is $9.86. The Score for MPX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.